Surrey Heartlands

Joint Formulary & PAD

Lisdexamfetamine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults

You are here : Home > Formulary Search > Lisdexamfetamine - Attention Deficit Hyperactivity Disorder (ADHD) - Adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
CD
SPC
Restrictions / Comments :
Important

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

Documentation

Guidelines (National)
NICE NG87 ADHD-diagnosis-and-management
Shared Care
CNS Stimulants in ADHD - Amber Shared Care - May 2016
Information
Adult ADHD - Referral Pathway for SABP - Feb 2013
Information
Adult ADHD - Shared Care FAQ - Sep 2014

PAD Profile

ChemicalSubstance :
Lisdexamfetamine
Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Adults
Group Name :
Keywords :
Attention Deficit Hyperactivity Disorder
Brand Names Include :
Elvanse
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Lisdexamfetamine is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Attention Deficit Hyperactivity Disorder (ADHD) - Adults.

Committee Recommendations (2)

02 Jul 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Follow link to Shared Care Principles and Communication letters Shared Care principles and Communication letters

04 May 16 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN agreed the Amber Shared Care document below